Fundz

Gradalis reported raising $12.7 Million in an initial SEC Form D filing, from an offering of $30 Million

PRIVATEJun 12, 2025$12.7M of $30M raised

Amount Raised

$12.7 Million

$12.7 Million sold, per SEC Form D (first sale Jun 5, 2025)

Round Type

Venture

DallasBiotechnologyHealth CareTherapeutics

Quick answer

Gradalis raised $12.7 Million in a funding round, dated June 5, 2025. Gradalis is based in Dallas, Texas, United States.

How much did Gradalis raise?
Gradalis raised $12.7 Million in a funding round on June 5, 2025.
What does Gradalis do?
Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 registration trial in patients with ovarian cancer.
Where is Gradalis based and how big is it?
Gradalis is based in Dallas, Texas, United States. Fundz records about 25 employees.
Who are the decision-makers at Gradalis?
Fundz holds 2 contacts at Gradalis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Gradalis that raised within 45 days of this round, from Fundz verified event records.

  • MapLight Therapeutics raised $188M on July 18, 2025.
  • GenSight Biologics raised $580K (Seed) on July 17, 2025.
  • Prime Medicine raised $24M (Funding Round) on July 16, 2025.
  • Compugen raised $3.5M (Seed) on July 15, 2025.
  • Oncomatryx Biopharma raised $15M on July 15, 2025.
  • Illimis Therapeutics raised $42M (Series B) on July 14, 2025.

Who to call at Gradalis, and when

A new round usually means Gradalis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gradalis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gradalis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gradalis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gradalis

Location

Dallas, Texas, United States

About

Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 registration trial in patients with ovarian cancer. The company’s proprietary bi-shRNA therapy platform, which has been proven in its clinical studies, can be utilized to silence a broad range of genes and is applicable to multiple cancer types.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gradalis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Gradalis's next move

See what Strategic adds

Gradalis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.